Write the hold in the margin first. Then the labeled milligram. Nothing here is sold or filled.
Pure Health Notes

Margin notes for reading - not a script, not a fill. Open the margin disclaimer.

Vardenafil · origin file · PHN-D1

The third PDE5 still opens on a 10 mg start

I open this folder on the usual 10 mg start, not on a claim that Bayer invented a class. Two PDE5 tablets were already on the shelf. The margin I keep: August 2003 Levitra, GSK on the U.S. desk, a later melt called Staxyn, and a QT line that never left the label. This desk locks the swallowed monograph at 5-10 mg. The library note you are reading stays on 10 mg because that is the labeled start most men actually meet.

  • Desk lock: 5-10 mg
  • This note: 10 mg start
  • Levitra: 19 Aug 2003
  • Staxyn ODT: 2010
Third PDE5 folder, 10 mg tablet on a QT caution stamp

The 10 mg start was already the story

I still open the Levitra 10 mg page before I open the origin dates. The milligram is the habit. The history is why the habit exists.

The orange 10 mg carton is the object I still see when a man says Levitra. Usual start. Once in twenty-four hours. About an hour before you actually need it. That is the note patients bring me, and it is also the note Bayer wrote into the first U.S. label.

This library page is not a second monograph. The swallowed profile lives on the vardenafil medicine page. What I keep here is the origin smear: who built the molecule, who walked it into a market that already had a first tablet, and why a later melt did not reset the clock.

Our desk locks the medicine page at 5-10 mg. That is a SERP choice and a counseling choice. Five milligrams is the cautious first mark for older men, hepatic impairment, and some alpha-blocker combinations. Ten milligrams is the labeled start for most adults. Twenty milligrams exists. I will name it. I will not pretend this note is about twenty.

If you came here hunting a bargain generic, you still inherited a 2003 label. Cheap vardenafil 10 mg is the same active moiety Bayer filed. The price dropped. The QT line did not. The nitrate ban did not. I write those two holds in the margin before I write 'generic.'

Peer line from the urology desk: origin stories do not change candidacy. A man on a nitrate spray is not a Levitra 10 mg candidate because the tablet is old, cheap, or 'third.' He is not a candidate because the class forbids the stack. History is interesting. The hold is not optional.

Two folders already sat on the shelf

Sildenafil had five years of brand gravity before Bayer's chemists got a U.S. stamp. March 1998 made 'the blue diamond' a household object. Any later PDE5 tablet walked into a room that already knew the joke, the timing, and the nitrate warning.

Tadalafil arrived in the same autumn as Levitra. November 2003. Longer half-life. A weekend story that marketing could actually tell. Levitra 10 mg landed in the three-month gap between an entrenched first tablet and a duration story that was easier to draw on a napkin.

That sandwich is the origin. Not a scandal. Not a failure of the molecule. A calendar problem. If you want the later evidence file - diabetes numbers, QT milliseconds, the thin head-to-head stack - it sits in the Levitra 10 mg evidence note. This page stays on how the folder got its tab.

I tell residents the same thing I write in the margin: third-to-market without a kinetic hook is a commercial bruise, not a clinical one. Men still get erections on vardenafil. Trials said so. The launch just never owned a sentence the public could repeat.

Some men later thanked the bruise. When sildenafil left a blue tinge they hated, a third short-acting generic was sitting there. When a plan wanted a cheaper 10 mg fill than the first brand, the third folder was useful. Origins explain the modest share. They do not erase the switch role.

August 2003 and the GSK desk

August 19, 2003 is the date I write on the tab. NDA 021400. Film-coated vardenafil as Levitra. Bayer built it. GlaxoSmithKline walked a lot of the U.S. detailing.

August 19, 2003 is the date I write on the tab before I write any adjective. Film-coated vardenafil hydrochloride. Levitra. Adult men with erectile dysfunction. Bayer HealthCare as the origin shop. GSK as the co-promotion muscle in the United States. Some markets also saw Schering-Plough on the letterhead. The molecule did not change when the letterhead did.

Co-promotion splits the cost of a sales force. It does not invent a reason to leave a first brand that already works. 'We bind PDE5 a bit tighter in a dish' is a chemist sentence. It is a weak detailing sentence. Patients do not feel IC50. They feel an hour, a meal, a headache, and whether the evening worked.

The first U.S. carton already carried the ladder most of us still recite: 2.5, 5, 10, and 20 mg film-coated. The recommended start for most men was 10 mg, taken about sixty minutes before sexual activity, not more than once a day. That start is why this library note keeps saying 10 mg even though the medicine page on this site locks 5-10.

I do not romanticize the partnership. Pfizer had a five-year head start and a cultural object. Lilly-ICOS had a half-life you could sell. Bayer/GSK had a competent tablet and a crowded autumn. Share stayed modest. The label stayed honest. Those two facts can live in the same margin.

If you are reading this because a search promised 'order Levitra 10 mg' as if the year were 2003, slow down. This site does not fill. The origin file is a teaching blotter. Bring the nitrate list and the rhythm list to a clinician who can see you. The 2003 stamp does not replace an exam.

Potency in a dish did not buy a market

Binding charts from the late 1990s still show up in slide decks. Vardenafil is structurally related to sildenafil and, in vitro, one of the more potent PDE5 inhibitors. Bayer designed for that. They did not stumble sideways out of an angina program the way the first tablet did.

Lab potency is a design goal. It is not a patient window. Onset stayed in the half-hour to hour range. Useful effect stayed in the four-to-five-hour band. Food still slowed and blunted a fatty meal. The man at the table did not receive a longer night because an enzyme assay looked prettier.

I write that distinction in the margin every time a reader asks why 'the stronger one' is not the default. Stronger in a dish means the milligram number on the carton is smaller. It does not mean a better erection than a well-timed sildenafil 50 mg or a tadalafil weekend, and it does not cancel QT language the siblings print more quietly.

The practical file for plates and clocks is how to take cheap vardenafil 10 mg after a light plate. Origins stop at why the tablet exists. Timing is why a first try fails after steak.

Peer line: if a trainee quotes IC50 as a reason to pick Levitra 10 mg over the first tablet, send them back to the duration row and the QT row. Those are the rows men live with. The dish is a footnote.

Staxyn as a later delivery note

June 2010 added a melt. Staxyn. Orodispersible vardenafil, 10 mg only, on the tongue, no water. Same active moiety. Different exposure. The FDA stamp did not create a fourth PDE5 drug. It created a second way to swallow the third one.

I keep a hard margin here: Staxyn 10 mg is not interchangeable with swallowed Levitra 10 mg. The melt runs a higher systemic exposure. Men who need a 5 mg start do not get an ODT step. Men who like discretion get a tablet that disappears without a glass. Those are different jobs.

Onset did not magically shrink because the tablet foams on the tongue. The habit is still about an hour. The fat rule still applies. Anyone who treats Staxyn as a 'faster Levitra' is reading a commercial sentence, not the clinical pharmacology page.

I mention Staxyn in an origin note because it is the last major U.S. delivery change on this molecule. After that, the story is generics, price, and the same holds. If you want the swallow-versus-melt counseling in one place, the timing note carries it. Here I only file the date and the non-equivalence.

Bayer kept the film-coated line. That mattered. A melt-only product would have stranded the 5 mg start. The origin file ends with two presentations of one drug, not a sequel molecule.

What the current label still inherited

Late 1990s

Bayer designs vardenafil as a tight PDE5 binder after sildenafil has already proved the class.

1998

Sildenafil launches and sets the public script any later tablet has to live beside.

19 Aug 2003

FDA approves film-coated Levitra. Usual start 10 mg. Bayer with GSK on the U.S. desk.

Nov 2003

Tadalafil arrives weeks later with a long half-life the market can actually name.

17 Jun 2010

Staxyn 10 mg ODT is approved. Same drug, higher exposure, not a Levitra 10 mg swap.

The current swallowed tablet still carries the 2003 bones. On-demand only. No daily vardenafil schedule the way tadalafil later earned. Maximum one dose in twenty-four hours. Nitrate contraindication, class-wide and non-negotiable. Alpha-blockers as a blood-pressure stack, often with a 5 mg first mark.

The distinctive inherited line is QT. Congenital long QT. Class I antiarrhythmics such as quinidine and procainamide. Class III such as amiodarone and sotalol. That language is louder on vardenafil than on the two tablets that boxed it in 2003. I treat it as part of the origin, not as a 2020 afterthought.

CYP3A4 is the other inherited pipe. Ketoconazole, itraconazole, ritonavir and other strong inhibitors push levels up. Grapefruit is a smaller, sloppier version of the same idea. The 10 mg start becomes a different exposure if the liver pipe is blocked. Origins include the metabolic neighborhood, not just the press release.

FDA's public label pages remain the primary stamp. I point readers to the FDA and to DailyMed when they want the current wording rather than my margin. Wording moves. The 2003 approval date does not.

Sildenafil's own origin, if you need the first folder, sits on the sildenafil medicine page. I will not retell that angina-to-erection story here. Levitra 10 mg is a designed follower. That is enough history for one blotter.

Filing the origin note

When I close this origin file I want three sentences left in the margin. Bayer built a potent short-acting PDE5 tablet on purpose. It arrived third, between a cultural first and a duration second. The 10 mg start and the QT line are what survived the marketing weather.

I do not file Levitra 10 mg as a disappointment. I file it as a switch tool and a generic price tool. Men who need a short window, who hated a visual side effect, or who need a cheaper 10 mg fill still use it. Men with a long-QT story or a class I or class III antiarrhythmic should not.

Cheap is a pharmacy adjective. It is not a safety adjective. A discounted 10 mg tablet still waits an hour, still hates a heavy plate, and still forbids a nitrate. If the price is why you clicked, read the holds anyway.

Last peer line: do not change a dose or start a PDE5 tablet from a library note. Talk to the clinician who has your list. This blotter is a margin. It is not a standing order.

Dr. Julian Frost portrait, urology margin desk

Reader mail

Reader questions on this article

Answered by Dr. Julian Frost, MD · Urology & men's sexual health

Origin-file questions from the margin. I answer as a urologist who still writes the 10 mg start after the QT line, not as a shop.

If Bayer designed Levitra 10 mg to be more potent in the lab, why do doctors not treat it as the strong one?

Because the man in the room does not live in an enzyme assay. Vardenafil's in-vitro potency is why the carton milligrams run smaller than sildenafil's. It is not why an evening succeeds. Onset, food, duration, headache, and the QT line decide the pick. I dose to a labeled window, not to a binding chart. If a 10 mg start is tolerated and timed, that is a fair trial. If it is not, I change the clock or the plate before I change the molecule. The medicine page on this desk is vardenafil - read the holds there before you treat 'potent' as 'better.'

Is Levitra just a copy of Viagra that arrived late?

Related scaffold, same PDE5 idea, not a photocopy. The visual-side-effect rate is often the reason I switch a man off sildenafil. The QT language is louder here. The kinetic window is in the same short-acting bucket - about an hour in, about four to five hours of useful effect. Late is a calendar fact. Copy is a lazy word. I will switch a man to cheap vardenafil 10 mg for tolerability or price. I will not tell him he bought a clone.

Why do you keep saying 'after two PDE5s' when tadalafil approved in the same season?

Because the public already had a first tablet, and the second long-acting story landed close enough to steal the oxygen. Sildenafil had years. Tadalafil had a half-life you could sell in one sentence. Levitra 10 mg had competence and a crowded autumn. That is the origin bruise. It is also why generic-era share looks different from launch-era share. The molecule did not suddenly improve in 2018. The price did.

What is Staxyn, and did it replace Levitra 10 mg?

Staxyn is orodispersible vardenafil, approved in 2010, 10 mg only, melts on the tongue. It did not replace the swallow. Exposure is higher, so I do not swap Staxyn 10 mg for Levitra 10 mg as if the number were the same object. No 5 mg ODT exists. If I need a cautious start, I use a swallowed tablet. If a man wants no glass of water, I talk about the melt and I still write the QT line. Delivery changed. The class rules did not.

Does a cheap generic 10 mg tablet mean the origin story no longer matters?

The press-release story no longer matters. The inherited holds do. Nitrates are still a hard no. Class I and class III antiarrhythmics are still a reason I pick a sibling. CYP3A4 inhibitors still raise levels. A discount does not shorten the hour and does not forgive a heavy plate. I like cheap when the candidate is clean. I do not like cheap as a way to skip the margin.

You mentioned a heart-rhythm warning. Is that from the 2003 launch or a later scare?

The thorough QT work sits in the label as a formal caution: therapeutic 10 mg and a high 80 mg dose both moved QTc in a healthy-man study, in the same neighborhood as a moxifloxacin control. Congenital long QT and class I or class III drugs are the practical box. It is not a 2003 rumor and it is not a reason for every man to get an ECG 'just because.' It is a med-list question I ask before I write the first 10 mg.

Can I take Levitra 10 mg if I use a nitrate spray for chest pain?

No. That is class-wide, not a Levitra quirk. PDE5 plus a nitrate can drop blood pressure in a way I will not bargain with. If you have used a PDE5 tablet, say so in an emergency department before anyone reaches for nitroglycerin. Washout is a clinician call based on which tablet and when. Do not test the stack at home. The origin date does not soften this.

This site locks 5-10 mg. Why does this note keep saying 10 mg?

Because 10 mg is the usual labeled start, and this library note is written for the search that names that start. The medicine page on this desk locks 5-10 so we do not stamp every page with twenty. Five milligrams is real and useful. Twenty milligrams is real and is a later step. I will titrate. I will not pretend the origin story is a 20 mg story. If you need the swallow-versus-meal habits, use the timing note, not this tab.

With generics everywhere, is there any reason to prefer this third tablet now?

Fit. Short window. A visual side effect on sildenafil. A price a plan will actually pay. A man who already knows he wants on-demand, not a daily tadalafil habit. Those are reasons. 'Because it is more potent in a dish' is not. 'Because a site said buy Levitra 10 mg' is not. I still start with the hold list. Then I pick a tablet a man can time. Then I give the trial more than one rushed night.

General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.

Last Updated

Pure Health Notes

Seven notes, twenty-one reads, three names in the margin.

Write the hold. Then the milligram. Ask Adaeze, Julian, or Helena. This desk does not fill a bottle.

Browse the medicines